Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Characterizing Inclusion and Exclusion Criteria in Clinical Trials for CAR-T Cellular Therapy Among Adults with Hematologic Malignancies

Jordon Jaggers, Heidi D. Klepin, MD, Tanya M. Wildes, MD, Rebecca L. Olin, MD, Andrew S. Artz, MD, Sarah A Wall, MD, Samantha Jaglowski, MDMPH, Basem M. William, MRCP,MD, Don M. Benson, Jr., MD PhD, Ashley E. Rosko, MD

Blood (2019) 134 (Supplement_1): 5819.

https://doi.org/10.1182/blood-2019-131504

Published: 2019

Journal Articles

Carcinocythemia with Microfilaria: Two Diverse Pathologies in One Case

Swagatika Samal, MBBS MD, Shruti Mishra, MBBS, MD PDF Hematology, Rasheeda Mohamedali, MBBS, Kishore Kumar, MBBS, MD DM

Blood (2019) 134 (Supplement_1): 4867.

https://doi.org/10.1182/blood-2019-131393

Published: 2019

Journal Articles

High-Dose Intravenous Immunoglobulin and Immunosuppressive Therapy Have Therapeutic Potential for Non-Infectious Myelopathy and Peripheral Neuropathy Following Cord Blood Transplantation

Michiho Ebihara, MD, Shinsuke Takagi, Yoshikazu Uesaka, MD PhD, Takashi Mitsuki, MD, Mitsuhiro Yuasa, MD, Kosei Kageyama, MD, Daisuke Kaji, MD, Yuki Taya, MD PhD, Aya Nishida, MD, Kazuya Ishiwata, MD, Hisashi Yamamoto, MD, Go Yamamoto, MD PhD, Yuki Asano-Mori, MD PhD, Yukako Koike, MD PhD, Shigeyoshi Makino, MD PhD, Akiko Yoneyama, MD PhD, Atsushi Wake, MD PhD, Naoyuki Uchida, MD PhD, Shuichi Taniguchi, MD PhD

Blood (2018) 132 (Supplement 1): 3390.

https://doi.org/10.1182/blood-2018-99-116308

Published: 2018

Journal Articles

Automated Multiparameter Flow Cytometry (MFC) Immunophenotyping for Reproducible Identification of High Risk Smoldering Multiple Myeloma (SMM)

Bruno Paiva, PhD, Sarah K. Johnson, PhD, Maria-Victoria Mateos, MD PhD, Daisy V. Alapat, MD, Noemi Puig, MD PhD, Miguel-T Hernandez, Fernando Escalante, Alfonso Garcia de Coca, MD PhD, Joan Bladé, Juan Jose Lahuerta, Quentin Lecrevisse, Jacques J.M. van Dongen, MD PhD, Alberto Orfao, MD PhD, Gareth J Morgan, MD PhD, Bart Barlogie, MD PhD, Jesus San Miguel, MD PhD

Blood (2016) 128 (22): 373.

https://doi.org/10.1182/blood.V128.22.373.373

Published: 2016

Journal Articles

Lower Rates of Influenza Infection Following Two Dose Series of High Dose Vaccination in Plasma Cell Disorders: Results of a Randomized, Double-Blind, Placebo-Assisted Clinical Trial

Andrew R Branagan, MD, Eamon Duffy, Terri L Parker, MD, Stuart Seropian, MD, Connor Foster, Lin Zhang, Rakesh Verma, PhD(MDcal Oncology), MBA, MS, BCA, BS, Daniel Zelterman, PhD, Geliang Gan, PhD, Debra S. Brandt, DO, Jeremy Kortmansky, David H Witt, MD, Thomas M Ferencz, RPh, Madhav V Dhodapkar, MD

Blood (2016) 128 (22): 2139.

https://doi.org/10.1182/blood.V128.22.2139.2139

Published: 2016

Journal Articles

Establishment and Characterization of a Panel of Patient-Derived Acute Leukemia Mouse Models As Emerging Platform for Translational Research

Eva Oswald, PhD, Gabriele Greve, Kerstin Klingner, Benedikt Hammerich, Dorothee Lenhard, Milena Pantic, PhD, Michael Luebbert, MD, Julia B. Schueler, DVM, PhD

Blood (2015) 126 (23): 2538.

https://doi.org/10.1182/blood.V126.23.2538.2538

Published: 2015

Journal Articles

No Survival Improvement for Central Nervous System Multiple Myeloma By the Use of Novel Anti-Myeloma Agents: The Greek Myeloma Study Group Experience

Blood (2014) 124 (21): 4752.

https://doi.org/10.1182/blood.V124.21.4752.4752

Published: 2014

Journal Articles

Myeloid Dysfunction in Sickle Cell Disease

Alessandra Romano, MD PhD, Nunziatina Laura Parrinello, PhD, Concetta Conticello, MD, Rossellina Rosso, MD, Perrotta Caterina, Grazia Colletta, MD, Benedetta Ximenes, Piera La Cava, Carmela RITA Meli, Francesco Di Raimondo, MD

Blood (2014) 124 (21): 4908.

https://doi.org/10.1182/blood.V124.21.4908.4908

Published: 2014

Journal Articles

Both Intermittent and Continuous Dosing Regimens Of Pomalidomide Mediate Broad Activation Of Innate and Adaptive Immunity In Relapsed/Refractory Myeloma: Results Of A Phase II Randomized Trial

Kavita Dhodapkar, MD, Lin Zhang, Rakesh Verma, Ph.D, Kartik Sehgal, MBBS, Mehmet H. Kocoglu, MD, Madhav V. Dhodapkar, MD

Blood (2013) 122 (21): 1949.

https://doi.org/10.1182/blood.V122.21.1949.1949

Published: 2013

Journal Articles

Myeloid Impairment Contributes to Immunoparesis in Multiple Myeloma but Not MGUS

Alessandra Romano, MD, PhD, Nunziatina Parrinello, Calogero Vetro, Piera La Cava, Annalisa Chiarenza, MD, PhD, Concetta Conticello, MD, Giuseppe A Palumbo, Francesco Di Raimondo

Blood (2012) 120 (21): 1831.

https://doi.org/10.1182/blood.V120.21.1831.1831

Published: 2012

Journal Articles

Brain Lymphoma Treatment with Chemotherapy or Chemoradiotherapy from an Institution

Hassan Jalaeikhoo, MD, Bahman Shafaeean, MD, Manoutchehr Keyhani, MD

Blood (2012) 120 (21): 4859.

https://doi.org/10.1182/blood.V120.21.4859.4859

Published: 2012

Journal Articles

Magnetic Resonance Brain Imaging in Regularly Transfused Beta Thalassemia Major and Intermedia Subjects and Prevalence of Thrombophilia Mutations

Patricia Jane Giardina, MD, Dorothy A. Kleinert, NP, MPH, CPNP, Suzanne O. Salamon, Linda A. Heier, MD

Blood (2012) 120 (21): 5175.

https://doi.org/10.1182/blood.V120.21.5175.5175

Published: 2012

Journal Articles

Multiparameter Flow Cytometry Analysis of Peripheral Blood T, NK and Dendritic Cells From High-Risk Smoldering Multiple Myeloma Patients Treated with Lenalidomide and Dexamethasone

Bruno Paiva, Lucía López-Corral, María-Belén Vidriales, Luis Ignacio Sánchez Abarca, Miguel T. Hernandez, Joan Bargay, Javier De La Rubia, Pilar Giraldo, Ana-Isabel Teruel, Laura Rosiñol, Albert Oriol, Jose Hernández, Felipe de Arriba, Graça Esteves, Jose Antonio Pérez Simón, María-Victoria Mateos, Jesus F San Miguel

Blood (2010) 116 (21): 1906.

https://doi.org/10.1182/blood.V116.21.1906.1906

Published: 2010

Journal Articles

Engraftment Capacity of Intratibialy Injected Multiple Myeloma Patient-Derived Bone Marrow-Cells In Vivo

Julia Schüler, Dagmar Wider, Kerstin Klingner, Heinz-Herbert Fiebig, Monika Engelhardt

Blood (2010) 116 (21): 3010.

https://doi.org/10.1182/blood.V116.21.3010.3010

Published: 2010

Journal Articles

Hematopoietic Stem Cell Therapy In Eight Patients with Metachromatic Leukodystrophy – Relevance of Post-Transplant Medication.

Judith Böhringer, Birgit Kustermann-Kuhn, PhD, Friederike Gieseke, PhD, Annika Erbacher, PhD, Michaela Döring, MD, Christiane Kehrer, MD, Peter Lang, MD, Ingeborg Krägeloh-Mann, MD, Rupert Handgretinger, MD, PhD, Ingo Müller, MD

Blood (2010) 116 (21): 3727.

https://doi.org/10.1182/blood.V116.21.3727.3727

Published: 2010

Journal Articles

“Antitumor Activity of Novel Anti-MM Agents and Combinations, the Proteasome Inhibitor Bortezomib and Multikinase Inhibitor Sorafenib, Both Applied as Monotherapy and in Combination in NOD/SCID-IL2-Receptor-Gamma-chain −/− (NSG) Mice Using a Intratibial Tumor Dissemination approach”.

Julia Schüler, Dagmar Wider, Dietmar Pfeifer, Josefina Udi, Heinz-Herbert Fiebig, Ralph M. Waesch, Monika Engelhardt

Blood (2009) 114 (22): 4912.

https://doi.org/10.1182/blood.V114.22.4912.4912

Published: 2009

Journal Articles

Influenza (flu) Vaccine Administration to Patients with Multiple Myeloma (MM) Prior to Autologous T-Cell Harvest Leads to Better Reconstitution of Flu Immunity After High Dose Melphalan and Autologous Stem Cell Transplant (ASCT) and Reinfusion of Primed Ex-Vivo Co-Stimulated Autologous T-Cells and Post-ASCT Second Flu Vaccination Than Post-ASCT Flu Vaccination Alone.

Edward A. Stadtmauer, MD, Dan T. Vogl, MD, Nicole A. Aqui, MD, Aaron P. Rapoport, MD, Kenyetta Macdonald, Heather Murphy, Rita Bhagat, RN, Patricia A. Mangan, APRN, BC, Anne Chew, PhD, Elizabeth Veloso, RN, JD, Bruce Levine, PhD, Robert H. Vonderheide, MD, DPhil, Carl H. June, MD, Kathleen Sullivan, MD

Blood (2009) 114 (22): 797.

https://doi.org/10.1182/blood.V114.22.797.797

Published: 2009

Journal Articles

A Progressive Acquired Von Willebrand Factor Inhibitor in a Patient with Type 1 Von Willebrand’s Disease, Persistent Antiphospholipid Antibodies and An IgA Paraprotein

Gary W Moore, David A Gurney, Bella Madan

Blood (2008) 112 (11): 5454.

https://doi.org/10.1182/blood.V112.11.5454.5454

Published: 2008

Journal Articles

Veno-Occlusive Disease of the Liver during Induction Therapy for Acute Lymphoblastic Leukemia

Athanasios Papadopoulos, Sr., George Ntaios, Georgia Kaiafa, Fotios I Girtovitis, Zoi Saouli, Zisis Kontoninas, Michael D. Diamantidis, Charalambos Andreadis, Christos Savopoulos, Apostolos Hatzitolios

Blood (2008) 112 (11): 3949.

https://doi.org/10.1182/blood.V112.11.3949.3949

Published: 2008

Journal Articles

Antitumor Activity in a Human Multiple Myeloma (MM) Model Using Sorafenib, Bortezomib, and Dexamethasone Treatment.

Julia Schüler, Dagmar Wider, Dietmar Pfeifer, Martin Wagner, Heinz-Herbert Fiebig, Monika Engelhardt

Blood (2008) 112 (11): 1720.

https://doi.org/10.1182/blood.V112.11.1720.1720

Published: 2008

NARROW

Characterizing Inclusion and Exclusion Criteria in Clinical Trials for CAR-T Cellular Therapy Among Adults with Hematologic Malignancies

Carcinocythemia with Microfilaria: Two Diverse Pathologies in One Case

High-Dose Intravenous Immunoglobulin and Immunosuppressive Therapy Have Therapeutic Potential for Non-Infectious Myelopathy and Peripheral Neuropathy Following Cord Blood Transplantation

Automated Multiparameter Flow Cytometry (MFC) Immunophenotyping for Reproducible Identification of High Risk Smoldering Multiple Myeloma (SMM)

Lower Rates of Influenza Infection Following Two Dose Series of High Dose Vaccination in Plasma Cell Disorders: Results of a Randomized, Double-Blind, Placebo-Assisted Clinical Trial

Establishment and Characterization of a Panel of Patient-Derived Acute Leukemia Mouse Models As Emerging Platform for Translational Research

No Survival Improvement for Central Nervous System Multiple Myeloma By the Use of Novel Anti-Myeloma Agents: The Greek Myeloma Study Group Experience

Myeloid Dysfunction in Sickle Cell Disease

Both Intermittent and Continuous Dosing Regimens Of Pomalidomide Mediate Broad Activation Of Innate and Adaptive Immunity In Relapsed/Refractory Myeloma: Results Of A Phase II Randomized Trial

Myeloid Impairment Contributes to Immunoparesis in Multiple Myeloma but Not MGUS

Brain Lymphoma Treatment with Chemotherapy or Chemoradiotherapy from an Institution

Magnetic Resonance Brain Imaging in Regularly Transfused Beta Thalassemia Major and Intermedia Subjects and Prevalence of Thrombophilia Mutations

Multiparameter Flow Cytometry Analysis of Peripheral Blood T, NK and Dendritic Cells From High-Risk Smoldering Multiple Myeloma Patients Treated with Lenalidomide and Dexamethasone

Engraftment Capacity of Intratibialy Injected Multiple Myeloma Patient-Derived Bone Marrow-Cells In Vivo

Hematopoietic Stem Cell Therapy In Eight Patients with Metachromatic Leukodystrophy – Relevance of Post-Transplant Medication.

“Antitumor Activity of Novel Anti-MM Agents and Combinations, the Proteasome Inhibitor Bortezomib and Multikinase Inhibitor Sorafenib, Both Applied as Monotherapy and in Combination in NOD/SCID-IL2-Receptor-Gamma-chain −/− (NSG) Mice Using a Intratibial Tumor Dissemination approach”.

A Progressive Acquired Von Willebrand Factor Inhibitor in a Patient with Type 1 Von Willebrand’s Disease, Persistent Antiphospholipid Antibodies and An IgA Paraprotein

Veno-Occlusive Disease of the Liver during Induction Therapy for Acute Lymphoblastic Leukemia

Antitumor Activity in a Human Multiple Myeloma (MM) Model Using Sorafenib, Bortezomib, and Dexamethasone Treatment.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only